Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
16.93
0.07 (0.42%)
At close: Aug 15, 2025, 3:59 PM
16.95
0.12%
After-hours: Aug 15, 2025, 07:36 PM EDT
Spyre Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 81.66M | 48.49M | 89.42M | 71.58M | 45.14M | 227.55M | 188.89M | 90.59M | 235.36M | 35.24M | 34.86M | 38.99M | 37.47M | 14.64M | 15.14M | 24.66M | 34.77M | 80.23M |
Short-Term Investments | 444.92M | 516.33M | 513.66M | 342.65M | 380.85M | 257.09M | 150.38M | 113.01M | n/a | 3.23M | 20.85M | 34.69M | 51.08M | 52.09M | 77.99M | 87.76M | 93.81M | 46.43M |
Long-Term Investments | n/a | n/a | n/a | n/a | 321K | 319K | 322K | 1.31M | 1.32M | 1.31M | 1.55M | 1.53M | 1.8M | 1.83M | 1.84M | 1.84M | 1.85M | n/a |
Other Long-Term Assets | n/a | 10K | 10K | 10K | 10K | 10K | 9K | 9K | 10K | 78K | 86K | 749K | 752K | 800K | 44K | 897K | 1.55M | 2.56M |
Receivables | 3.5M | n/a | n/a | n/a | n/a | n/a | n/a | 163K | 1.65M | 330K | 375K | 669K | 479K | 1.01M | 815K | n/a | n/a | 21.5M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.75M | 4.95M | 5.39M | 6.85M | 9.74M | 2.63M | 2.25M | 2.19M | 2.88M | 5.57M | 6.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 538.83M | 569.77M | 608.47M | 421.08M | 435.74M | 487.27M | 341.53M | 205.95M | 239.89M | 44.38M | 62.26M | 82.22M | 96.65M | 72.6M | 98.89M | 117.51M | 134.37M | 151.41M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.32M | 6.69M | 7.25M | 7.07M | 7.5M | 7.95M | 9.15M | 8.81M | 9.22M | 9.64M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | 10K | 10K | 10K | 331K | 329K | 331K | 1.32M | 3.64M | 8.08M | 8.89M | 9.35M | 10.06M | 10.57M | 11.04M | 11.55M | 12.61M | 12.2M |
Total Assets | 538.83M | 569.78M | 608.48M | 421.09M | 436.07M | 487.6M | 341.86M | 207.26M | 243.53M | 52.45M | 71.14M | 91.57M | 106.71M | 83.17M | 109.93M | 129.06M | 146.98M | 163.61M |
Account Payables | 3.71M | 3.69M | 666K | 5.17M | 3.23M | 3.11M | 896K | 1.68M | 2.85M | 2.06M | 677K | 4.18M | 1.96M | 2.98M | 3.32M | 1.86M | 2.22M | 1.88M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 930K | 302K | 517K | 505K | 291K | 2.07M | 2.36M | 4.79M | 5.53M | 19.23M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 76.06M | 44.74M | 52.79M | 52.37M | 16.23M | 37.21M | 27.03M | 18M | 196.07M | 6.81M | 4.92M | 7.72M | 9.47M | 8.4M | 4.99M | 9.67M | 9.54M | 2.1M |
Total Current Liabilities | 83.06M | 70.68M | 54.06M | 57.54M | 22.12M | 42.82M | 31.98M | 44.87M | 232.23M | 12.64M | 14.66M | 17.68M | 15.86M | 16.3M | 20.14M | 20.43M | 20.6M | 32.37M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 253.41M | 84.56M | 387.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 16.49M | 36.62M | 36.16M | 39.56M | 39.11M | 41.31M | 20.69M | 216.32M | n/a | n/a | n/a | n/a | 8K | n/a | 192K | 200K | 206K |
Total Long-Term Liabilities | n/a | 16.49M | 36.62M | 36.16M | 39.56M | 292.51M | 125.86M | 407.8M | 218.66M | 6.16M | 6.18M | 6.33M | 6.69M | 5.21M | 5.84M | 6.55M | 7.35M | 7.49M |
Total Liabilities | 83.06M | 87.17M | 90.68M | 93.7M | 61.68M | 335.33M | 157.84M | 452.67M | 450.9M | 18.8M | 20.84M | 24.01M | 22.55M | 21.51M | 25.98M | 26.98M | 27.96M | 39.86M |
Total Debt | n/a | n/a | n/a | n/a | n/a | 253.41M | 84.56M | 387.11M | 4.33M | 4.43M | 4.64M | 4.75M | 4.79M | 4.93M | 5.48M | 5.16M | 5.29M | 5.32M |
Common Stock | 155.83M | 13K | 13K | 12K | 12K | 10K | 10K | 7K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K |
Retained Earnings | -1.05B | -1.02B | -972.43M | -916.14M | -847.11M | -808.27M | -764.41M | -701.23M | -661.13M | -444.05M | -425.62M | -406.8M | -388.57M | -366.25M | -341.81M | -321.36M | -301.06M | -294.23M |
Comprehensive Income | 454K | 682K | 180K | 1.46M | -553K | -363K | 302K | -132K | 11K | -6K | -48K | -184K | -220K | -153K | -20K | 2K | 11K | 25K |
Shareholders Equity | 455.77M | 482.61M | 517.8M | 327.39M | 374.38M | 152.27M | 184.02M | -245.4M | -207.37M | 33.65M | 50.3M | 67.56M | 84.16M | 61.66M | 83.94M | 102.08M | 119.02M | 123.75M |
Total Investments | 444.92M | 516.33M | 513.66M | 342.65M | 381.17M | 257.41M | 150.38M | 113.01M | 1.32M | 3.23M | 22.4M | 36.22M | 52.88M | 53.92M | 79.82M | 89.6M | 95.66M | 46.43M |